Study of blood coagulation profile to predict the risk of complications in high risk pregnancy
Not Applicable
- Registration Number
- CTRI/2021/07/034998
- Lead Sponsor
- Maulana Azad Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All low and high risk pregnant women in third trimester gestation period from 29th to 40th week of pregnancy
Exclusion Criteria
Patient taking drugs that could affect coagulation profile
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assess the Prothrombin time, Activated partial <br/ ><br>thromboplastin time, Thrombin time, International normalized ratio(INR), Fibrinogen, <br/ ><br>Fibrin degradation products(FDP), D-Dimer levels in low and high risk pregnant <br/ ><br>women.Timepoint: 1 year <br/ ><br>
- Secondary Outcome Measures
Name Time Method Assess the association between altered <br/ ><br>coagulation profile and pregnancy complications such as Postpartum haemorrhage, <br/ ><br>Intrauterine death, Deep vein thrombosis and other Venous thromboembolismTimepoint: 1 year